Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia.
about
The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions.Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial.Chemoreflexes, sleep apnea, and sympathetic dysregulationObstructive sleep apnea and hypertension: an update.Inflammation in sleep apnea: an update.Impact of medications on cognitive function in obstructive sleep apnea syndrome.Pleiotropic effects of statins: new therapeutic targets in drug design.Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.The impact of chronic intermittent hypoxia on hematopoiesis and the bone marrow microenvironment.High-intensity training reduces intermittent hypoxia-induced ER stress and myocardial infarct size.Nonmuscle Myosin Light Chain Kinase: A Key Player in Intermittent Hypoxia-Induced Vascular Alterations.Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.Increased cardiac output contributes to the development of chronic intermittent hypoxia-induced hypertension.Impairment of vascular strain in patients with obstructive sleep apnea.
P2860
Q30428971-3145B768-04A6-4690-91CE-940BD4C71F7FQ34152828-3D3A4B7F-8375-4D43-9FE5-E91751135CE9Q34598170-661EE90D-4EBC-468C-99E0-71DB99F2C157Q34598539-4C12362D-A444-430D-AD4A-BFC259B052A2Q35137720-D32C0516-E403-401B-B06F-C825A1B8101CQ38310541-0EEB270A-93CB-413F-84F1-3A9E6D2FCD1DQ38825843-FA5EDA96-DE23-4761-8EDC-FFF989D53D21Q38919168-2D5A313F-F38D-456B-A0B5-09C1A636EBA4Q40013723-7BDBEF56-D844-45F1-BE73-66439D847D75Q47347389-527B7500-8ECE-41AD-800D-71BB2120BD00Q47640619-6FD23923-12CE-4C77-9A45-B438D369F716Q47799206-A8312199-7B7B-4843-8C74-21A40D4294F9Q47837399-FE993A5F-2241-417A-B340-07B85105EBF8Q55169774-E9B9BC00-0F44-4ACC-970C-23B90B9F5E45
P2860
Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Atorvastatin protects against ...... chronic intermittent hypoxia.
@en
Atorvastatin protects against ...... chronic intermittent hypoxia.
@nl
type
label
Atorvastatin protects against ...... chronic intermittent hypoxia.
@en
Atorvastatin protects against ...... chronic intermittent hypoxia.
@nl
prefLabel
Atorvastatin protects against ...... chronic intermittent hypoxia.
@en
Atorvastatin protects against ...... chronic intermittent hypoxia.
@nl
P2093
P2860
P50
P356
P1476
Atorvastatin protects against ...... y chronic intermittent hypoxia
@en
P2093
Christophe Ribuot
Gilles Faury
Irina Korichneva
Marie Baldazza
Perle Totoson
Sandrine Cachot
Wassim Fhayli
P2860
P304
P356
10.1177/1535370212473696
P577
2013-02-12T00:00:00Z